SEC Form 4 · accession 0001144204-15-058987
Inspyr Therapeutics, Inc. · NSPX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig A Dionne
Officer — CEO, CFO, President · Director · 10% Owner
Period of report
Oct 6, 2015
Accepted (ET)
Oct 9, 2015 · 8:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001421204
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 6, 2015 | J | 415,738 | $0.00 | A | 2,446,747 | D | |
| Common StockF2 | Oct 6, 2015 | J | 1,000,000 | $0.00 | D | 1,446,747 | D | |
| Common StockF1 | Oct 6, 2015 | J | 415,738 | $0.00 | D | 18,002 | I | As Trustee of the Dionne Annuity Trst of 2011 |
| Common StockF2 | Oct 6, 2015 | J | 500,000 | $0.00 | A | 500,000 | I | Reporting Person's spouse is Trustee and Beneficiary of the Dionne 2015 GRAT #1 Trust |
| Common StockF2 | Oct 6, 2015 | J | 500,000 | $0.00 | A | 500,000 | I | As Trustee and Beneficiary of the Dionne 2015 GRAT #2 Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Disclosing a transfer of 415,738 common shares from the Dionne Annuity Trust of 2011 to Reporting Person in accordance with estate planning.
- F2Disclosing a transfer of 1,000,000 common shares from Reporting Person to the following in accordance with estate planning: (i) 500,000 Dionne 2015 GRAT #1 Trust and (ii) 500,000 to Dionne 2015 GRAT #2 Trust.